← Every company
Kura Oncology Inc Planned Sales
Before an insider at Kura Oncology Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
KURA insider trades →Notices on file
10
Insiders
9
Shares noticed
118K
permission to sell, not sales
Estimated value
$1.3M
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Leoni MollieOfficer2026-09-2928.8K sh0.03% | $305.6K |
| J Burrows FrancisOfficer2026-09-2420.7K sh0.02% | $224.5K |
| Powl BrianOfficer2026-09-2915.4K sh0.02% | $163.7K |
| Mollie LeoniOfficer2026-09-2812.4K sh0.01% | $133.9K |
| Brian T PowlOfficer2026-09-289K sh<0.01% | $97.1K |
| Teresa Brophy BairOfficer2026-09-288.4K sh<0.01% | $90.8K |
| Powl BrianOfficer2026-09-288K sh<0.01% | $86.1K |
| Kathleen FordOfficer2026-09-286.9K sh<0.01% | $74.3K |
| Thomas James DoyleOfficer2026-09-284.6K sh<0.01% | $49.6K |
| Ford KathleenOfficer2026-09-293.7K sh<0.01% | $38.9K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on KURA
Company overviewEverything on KURA in one place, with the price.SEC filingsWhat KURA's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat KURA's own officers and directors buy and sell.Executive payWhat KURA awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in KURA.Funds holding itWhich funds and ETFs hold KURA, and how big a bet.PatentsWhat KURA is filing at the patent office.